Advanced Search

Amendments To The Cabinet Of 23 March 2010 No. 288 In The Terms Of The "provisions On The Operation Of Pharmacies"

Original Language Title: Grozījumi Ministru kabineta 2010.gada 23.marta noteikumos Nr.288 "Aptieku darbības noteikumi"

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.
Cabinet of Ministers Regulations No. 377 in 2015 (July 7. No 32 20) amendments to the Cabinet of 23 March 2010 No. 288 "the provisions of the pharmacy operation regulations" Issued in accordance with article 5 of the law of Pharmacy 1 do Cabinet of 23 March 2010 No. 288 "the provisions of the pharmacy operation regulations" (Latvian journal, 2010, 51-52 No; 13, no. 208) the following amendments: 1. provisions supplementing with 8.1 point as follows: "If the pharmaceutical care 8.1 within the Pharmacy and drugstore branch of health visitors to support out of self-control that provision referred to in paragraph 28.1 health self-control that made contact with the blood, the Pharmacy and the pharmacy branch has a separate reception room where health self-control do, without affecting its quality, as well as the staff and visitor safety. If this rule 28.1 health referred to in paragraph 1, not for self checking contact with blood, the Pharmacy and the pharmacy Branch Office is a separate room or separate site visitor service Hall, which can smoothly perform measurements. " 2. Supplement with 11.1 points as follows: "Pharmacy and drugstore 11.1 branch, which provides for the provision of health referred to in paragraph 28.1 self-control: 11.1 1. provide health self-control necessary for medical devices, consumables and accessories to the sampling, as well as to ensure that their operation and the technical supervision of compliance with the regulations on the registration of medical devices, conformity assessment, distribution, operation and technical supervision in a specific order; 11.1 2. provide visitor information on available health self-control and instructions regarding the taking of samples; 11.1 3. visitor study results issued a report containing the following information: 11.1 3.1. pharmacies and pharmacy branch name, address and telephone number; 11.1 3.2 visitor's first name, last name; 11.1 3.3. study type; 3.4. the study results 11.1; 11.1 the person 3.5 name and specialty, which made the measurements; 11.1 3.6. date and time of the examination. " 3. Make the following paragraph 13: "13. If the drugstore or pharmacy Branch issued the special permissions (licenses) or general open pharmacies (operation) to open the attachment contains the special operating conditions – manufacturing of medicinal products in pharmacies in the pharmacy or pharmacy branch has furnished room (rooms) non-sterile dosage forms and sterile for the manufacture of dosage forms for the manufacture of aseptic conditions, as well as the manufacturing process to provide the necessary utility room. " 4. Supplement with 13.6. subparagraph by the following: "13.6. procedures carried out this provision in paragraph 28.1 health self-control (if provided), including the safe disposal of the target samples and their destruction according to the laws and regulations on medical waste management authorities."
5. Add to 25.4. section behind the words "work" with the words "as well as ensuring that servicing the visitors, pharmacist and a pharmacist Assistant to clothes worn in a visible place certificate-issued pin according to the legislation on pharmacists and pharmacist Assistant registration order". 6. Supplement with 28.1 points as follows: "the pharmaceutical care within 28.1 Pharmacy and pharmacy branch can offer visitors to make such health self-control: 28.1 1. cholesterol and triglyceride level of blood; 28.1 2. glucose level blood with glikometr; 28.1 3. Pulse frequency and arterial blood pressure measurement; 28.1 4. weight or body mass index. " 7. Put the following section 30.2. the: 30.2. "prescription drugs is a label that is easily legible written information containing at least the following information: pharmacy or pharmacy 30.2.1. branch name, address and telephone number; 30.2.2. the patient name, which discharged certain medicines; 30.2.3. name of the medicinal product, dose and quantity; 30.2.4. guidelines for the use of the medicinal product; 30.2.5. specific use or storage conditions (if provided); 30.2.6. date of issue of the medicinal products; ". 8. Supplement with 30.5. subparagraph by the following: "5. the label that the size is not smaller than 40 x 58 mm and containing this rule 30.2. of the information referred to in the attached secondary or primary packaging (if there is no secondary packaging or secondary packaging is divided, intact primary packaging) designated area or, failing that, to another location, without obscuring the Braille, drug expiration date and serial number." 9. Express 40. the fourth sentence as follows: "the pharmacy or pharmacy branch, where special permission (license), or general open pharmacies opening (action) is not listed in the annex to the special operating conditions – manufacture of medicines the pharmacy, the pharmacist takes the patient's prescription drug manufacture and provide other pharmacy or pharmacy branch, where special permission (license), or general open pharmacies (operation) to open the attachment contains the special operating conditions – manufacturing of medicinal products in pharmacies and can supply pharmacy or pharmacy branch, in which the patient is transferred the recipe. " 10. paragraph 43 be worded as follows: "43. If the drugstore or pharmacy Branch issued the special permissions (licenses) or general open pharmacies opening (action) is not listed in the annex to the special operating conditions – manufacturing of medicinal products in pharmacies, the pharmacy or pharmacy Branch contracts for the manufacture of medicinal products or the pharmacies pharmacy branch where special permission (license), or general open pharmacies (operation) to open the attachment contains the special operating conditions – manufacture of medicines in pharmacies. " 11. Supplement with 47.2 and 47.3 points as follows: "this provision 8.1 47.2, 11.1 points, 13.6.28.1 points and shall enter into force on January 1, 2016. 47.3 prescription design not later than by 1 January 2016 to be 30.5. these provisions referred to in subparagraph label. " Prime Minister-Minister of traffic Anrij matīss Guntis Belēvič Minister of health in the